Nomogram to Predict Left Atrial Thrombus or Spontaneous Echo Contrast in Patients With Non-valvular Atrial

Zhitong Li1, Quanbo Liu2, Fei Liu1

  • 1Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.

Insights

A new nomogram effectively predicts left atrial thrombus (LAT) or spontaneous echo contrast (SEC) in non-valvular atrial fibrillation (NVAF) patients, outperforming existing scores. This tool aids in personalized risk assessment for better clinical decisions.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Clinical Risk Prediction

Background:

  • Existing CHADS 2 and CHA 2DS 2-VASc scores have modest predictive power for left atrial thrombus (LAT)/spontaneous echo contrast (SEC) in non-valvular atrial fibrillation (NVAF).
  • Accurate prediction of LAT/SEC is crucial for stroke risk stratification in NVAF patients.

Purpose of the Study:

  • To identify clinical and ultrasonic variables associated with LAT/SEC in NVAF.
  • To develop and validate a nomogram for individual risk prediction of LAT/SEC.

Main Methods:

  • Analysis of 1,813 NVAF patients undergoing transesophageal echocardiography (TEE).
  • Univariate and multivariate logistic regression to construct a nomogram.
  • Assessment of nomogram performance using calibration, discrimination (AUC), and clinical usefulness.

Main Results:

  • Left atrial thrombus/spontaneous echo contrast detected in 21.0% (training) and 21.6% (validation) cohorts.
  • Independent predictors identified: Age, left atrial diameter (LAD), left ventricular ejection fraction (LVEF), hypertension (HTN), prior stroke/TIA, and non-paroxysmal AF.
  • The nomogram demonstrated good predictive ability with concordance indexes of 0.836 (training) and 0.794 (validation).

Conclusions:

  • A novel nomogram incorporating six key patient characteristics was developed for predicting LAT/SEC in NVAF.
  • The nomogram shows good calibration, discrimination, and clinical utility.
  • This tool offers significant value for personalized risk prediction of LAT/SEC in NVAF patients.

Related Concept Videos

Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
418
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
43
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
45